News of Note—Bavarian Nordic, FluGen and more


Here is some other vaccine news of note for the week:

> Bavarian Nordic shipped Imvanex smallpox vaccine doses to England after authorities there recorded monkeypox cases. Release

> The National Institutes of Health is supporting phase 1 testing of a broadly protective flu vaccine developed by FluGen. Release

> Sinovac reports that the U.S. Department of Justice has closed an investigation into the company. Release

> In a preclinical study, an experimental H3N2 flu DNA vaccine from Inovio elicited antibody responses and protected against a heterologous lethal challenge. Release

Suggested Articles

Merck's HPV vaccine Gardasil is delivering blockbuster sales as demand surges. But high demand has caused somewhat of a supply constraint.

GSK's Shingrix has generated blockbuster sales early in the launch, but there's a lot of remaining opportunity, an exec said at JPM.

Quickly after Merck's world-first Ebola vaccine approval in Europe, U.S. authorities licensed the shot.